Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6499
    +0.0010 (+0.15%)
     

  • OIL

    82.84
    -0.52 (-0.62%)
     

  • GOLD

    2,328.90
    -13.20 (-0.56%)
     

  • Bitcoin AUD

    98,858.47
    -3,382.89 (-3.31%)
     

  • CMC Crypto 200

    1,385.35
    -38.75 (-2.72%)
     

  • AUD/EUR

    0.6069
    +0.0012 (+0.20%)
     

  • AUD/NZD

    1.0942
    +0.0011 (+0.10%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer

David Jagielski, The Motley Fool
·4-min read
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer

Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are two healthcare companies aiming to produce a vaccine for the respiratory syncytial virus (RSV). In trials, their vaccine candidates have been proving highly effective, and it may not be long before these COVID-19 vaccine makers are fighting for market share again -- this time in the RSV market. The Food and Drug Administration (FDA) recently approved an RSV vaccine, and it wasn't from either of these two companies.

Continue reading